Sep 6, 2016
New Drug Clears Abnormal Brain Proteins Tied to Alzheimer’s
Posted by Dan Kummer in categories: biotech/medical, neuroscience
In people with Alzheimer’s disease, a new investigational drug can dramatically reduce the amount of amyloid beta plaque, the tangled clumps of proteins that form in the brains of Alzheimer’s patients, according to a new early study of the drug.
The drug works by spurring the immune system to recognize and clear the plaques.
“We believe that’s a hint of efficacy,” study co-author Dr. Alfred Sandrock, a neurologist and an executive vice president at Biogen, said during a news briefing. “We believe that needs to be confirmed with further studies.” Biogen is the Cambridge, Massachusetts, company that funded the trial and applied to patent the drug. [10 Things You Didn’t Know About the Brain].
Continue reading “New Drug Clears Abnormal Brain Proteins Tied to Alzheimer’s” »